The establishment of diagnosis is usually late with anemia as a clinical symptom, and through blood test, hemoglobin electrophoresis. However, due to the development of biotechnology science, prenatal diagnosis to carrier screening based on autosomal recessive shows the promise in Thalassemia diagnosis and treatment.